D

Denali Therapeutics Inc.

DNLI NASDAQ Healthcare · Biotechnology www.denalitherapeutics.com
$24.35
Mkt Cap 3.86B
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$3.6M
20.7% CAGR
FCF TTM
-$447.6M
-12418.8% margin
Running full 6-factor analysis…